Activation of H19 could be potential strategy to improve muscle IR and T2DM via multi pathways such as blocking H19/let-7 vicious cycle, inactivating histone HDAC6 to upregulate IRS1 and interacting with hnRNPA1 to increase fatty acid oxidation genes. The gene discussed is HNRNPA1; the disease is type 2 diabetes mellitus.